+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tuberculosis Testing Market by Test Type (Culture Test, Immunological Test, Molecular Test), End User (Clinics, Hospitals, Reference Laboratory), Technology, Sample Type, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Tuberculosis Testing Market by Test Type (Culture Test, Immunological Test, Molecular Test), End User (Clinics, Hospitals, Reference Laboratory), Technology, Sample Type, Distribution Channel, Application - Global Forecast 2025-2030- Product Image
Sale

Tuberculosis Testing Market by Test Type (Culture Test, Immunological Test, Molecular Test), End User (Clinics, Hospitals, Reference Laboratory), Technology, Sample Type, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4985927
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The tuberculosis testing market is evolving rapidly as healthcare systems and industry leaders respond to demand for faster, more accurate, and more accessible diagnostics. With innovation driving new opportunities and challenges in clinical and public health settings, strategic investment in the right platforms is critical for competitive advantage.

Market Snapshot: Tuberculosis Testing Market

The tuberculosis testing market grew from USD 2.38 billion in 2024 to USD 2.52 billion in 2025. It is expected to continue growing at a CAGR of 5.95%, reaching USD 3.36 billion by 2030. Market expansion is propelled by the integration of advanced diagnostic technologies, with a strong emphasis on both high-sensitivity detection and broader access in diverse healthcare environments. These trends reflect mounting public health priorities and the need for strategic coordination among diagnostic manufacturers, providers, and regulatory bodies.

Scope & Segmentation

  • Test Types: Culture testing, immunological assays (Elisa, Western Blot), molecular diagnostics, rapid diagnostic tests (chromatographic, lateral flow).
  • End Users: Clinics, hospitals, reference laboratories.
  • Technologies: Culture-based systems, immunodiagnostics, lipoarabinomannan assays, nucleic acid amplification tests.
  • Sample Types: Blood, sputum, urine.
  • Distribution Channels: Diagnostic laboratories, hospital pharmacies, online pharmacies.
  • Applications: Active tuberculosis, latent tuberculosis.
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Cepheid, QIAGEN, Hain Lifescience, Roche Diagnostics, Abbott, Becton Dickinson, Bio-Rad, Thermo Fisher, Siemens Healthineers, bioMérieux.

Key Takeaways: Strategic Insights for Decision-Makers

  • Technological advances in tuberculosis diagnostics now encompass microfluidics, point-of-care testing, and AI-driven analytics, improving case detection and enabling decentralized models suitable for resource-limited settings.
  • Integration of digital diagnostics supports remote monitoring and telepathology, addressing workforce and expertise constraints while accelerating clinical workflows and facilitating epidemiological surveillance.
  • Collaboration between assay developers, reagent manufacturers, and contract producers improves supply chain resilience, particularly as global events and policy changes create new challenges in sourcing and distribution.
  • The emergence of ultra-sensitive molecular assays and novel biomarker platforms is enhancing detection of both active and latent tuberculosis, supporting real-time treatment decisions and monitoring of efficacy.
  • Manufacturers are increasingly focusing on end-to-end solutions that include hardware, assay kits, and digital platforms to streamline user experience and align with healthcare provider needs across multiple care settings.
  • Regional adaptation remains vital, with diagnostics deployment strategies varying by funding models, infrastructure, and policy priorities across Americas, EMEA, and Asia-Pacific.

Tariff Impact: United States 2025 Supply Chain Dynamics

New tariffs imposed in 2025 on imported diagnostic reagents and equipment have increased procurement complexity for laboratories. These measures have prompted manufacturers to diversify supply networks, explore regional production, and invest in alternative reagent formulations. Regulatory agencies have accelerated processes for domestic test approvals and fostered public-private partnerships to boost local manufacturing, reinforcing supply chain stability and driving ongoing adaptation in delivery models and pricing strategies.

Methodology & Data Sources

This report leverages a vigorous qualitative and quantitative research process, drawing from peer-reviewed publications, regulatory filings, policy materials, and direct interviews with key opinion leaders. Market insights were validated and triangulated across sources, ensuring reliability, transparency, and an accurate depiction of both prevailing trends and emerging challenges in tuberculosis diagnostics.

Tuberculosis Testing Market: Why This Report Matters

  • Empowers senior leaders to identify high-value investment opportunities and anticipate regulatory and supply chain risks shaping the diagnostic landscape.
  • Enables targeted market entry, partnership, and innovation strategies calibrated to evolving technologies and region-specific requirements.
  • Delivers actionable intelligence on emerging disruptors, advanced test modalities, and effective channel management to support informed decision-making.

Conclusion

The tuberculosis testing market is experiencing transformative change as technological and regulatory shifts reshape diagnostics. Strategic investment in adaptable platforms and collaborative models will be central to success in meeting the diagnostic needs of a diverse global population.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid molecular testing platforms integrated with AI enabled decision support for multi drug resistant TB detection in remote clinics
5.2. Expansion of point of care immunodiagnostic assays targeting latent tuberculosis infection detection in community outreach programs
5.3. Increased regulatory approvals and government funding incentives accelerating development of next generation CRISPR based TB diagnostic tests
5.4. Integration of smartphone microscopy and cloud based data analytics for remote tuberculosis smear examination and monitoring
5.5. Scaling of fully automated sample to answer nucleic acid amplification platforms to reduce turnaround time in high burden regions
5.6. Collaboration between pharmaceutical companies and public health agencies to expand mass screening initiatives in urban slums
5.7. Adoption of multiplexed biomarker panels combining host immune response and pathogen detection for improved TB diagnosis accuracy
5.8. Implementation of decentralized testing networks utilizing mobile laboratories to address TB outbreaks in remote communities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tuberculosis Testing Market, by Test Type
8.1. Introduction
8.2. Culture Test
8.2.1. Liquid Culture
8.2.2. Solid Culture
8.3. Immunological Test
8.3.1. Elisa
8.3.2. Western Blot
8.4. Molecular Test
8.4.1. Line Probe Assay
8.4.2. Pcr
8.5. Rapid Diagnostic Test
8.5.1. Chromatographic
8.5.2. Lateral Flow
9. Tuberculosis Testing Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
9.4. Reference Laboratory
10. Tuberculosis Testing Market, by Technology
10.1. Introduction
10.2. Culture Based Technology
10.3. Immunodiagnostic
10.4. Lipoarabinomannan Assay
10.5. Nucleic Acid Amplification Test
11. Tuberculosis Testing Market, by Sample Type
11.1. Introduction
11.2. Blood
11.3. Sputum
11.4. Urine
12. Tuberculosis Testing Market, by Distribution Channel
12.1. Introduction
12.2. Diagnostic Laboratory
12.3. Hospital Pharmacy
12.4. Online Pharmacy
13. Tuberculosis Testing Market, by Application
13.1. Introduction
13.2. Active Tuberculosis
13.3. Latent Tuberculosis
14. Americas Tuberculosis Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Tuberculosis Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Tuberculosis Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Cepheid, Inc.
17.3.2. QIAGEN N.V.
17.3.3. Hain Lifescience GmbH
17.3.4. Roche Diagnostics International Ltd
17.3.5. Abbott Laboratories
17.3.6. Becton Dickinson and Company
17.3.7. Bio-Rad Laboratories, Inc.
17.3.8. Thermo Fisher Scientific Inc.
17.3.9. Siemens Healthineers AG
17.3.10. bioMérieux SA
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TUBERCULOSIS TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TUBERCULOSIS TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TUBERCULOSIS TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. TUBERCULOSIS TESTING MARKET: RESEARCHAI
FIGURE 28. TUBERCULOSIS TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. TUBERCULOSIS TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. TUBERCULOSIS TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TUBERCULOSIS TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIQUID CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIQUID CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SOLID CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SOLID CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LINE PROBE ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LINE PROBE ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CHROMATOGRAPHIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CHROMATOGRAPHIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REFERENCE LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REFERENCE LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNODIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNODIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIPOARABINOMANNAN ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIPOARABINOMANNAN ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SPUTUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SPUTUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ACTIVE TUBERCULOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ACTIVE TUBERCULOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATENT TUBERCULOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATENT TUBERCULOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 130. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 131. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 132. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 133. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 134. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 135. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 136. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 137. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 150. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 151. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 152. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 153. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 154. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 155. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 156. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 252. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 253. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 254. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 255. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 256. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 257. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 258. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 259. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 272. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 273. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 274. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 275. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 276. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 277. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 278. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 279. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 310. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 311. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 312. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 313. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 314. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2025-2030 (USD MILLION)
TABLE 315. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 316. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 317. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
TABLE 318. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2025-2030 (USD MILLION)
TABLE 319. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 324. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 325. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 330. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 331. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2024 (USD MILLION)
TABLE 332. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2025-2030 (USD MILLION)
TABLE 333. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2024 (USD MILLION)
TABLE 334. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL T

Samples

Loading
LOADING...

Companies Mentioned

  • Cepheid, Inc.
  • QIAGEN N.V.
  • Hain Lifescience GmbH
  • Roche Diagnostics International Ltd
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • bioMérieux SA

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.36 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Mycobacterium Tuberculosis Test Kit Market by Technology (Culture Methods, Immunological Tests, Microscopy Tests), Application (Diagnostic Testing, Drug Susceptibility Testing), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Mycobacterium Tuberculosis Test Kit Market by Technology (Culture Methods, Immunological Tests, Microscopy Tests), Application (Diagnostic Testing, Drug Susceptibility Testing), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Tuberculosis Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular, Nonmolecular), Test Type, End User, Application - Global Forecast 2025-2030 - Product Image

Tuberculosis Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular, Nonmolecular), Test Type, End User, Application - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Tuberculosis Diagnostics Market Size, Share, Trends and Forecast by Disease Stage, Test Type, End-User, and Region, 2025-2033 - Product Image

Tuberculosis Diagnostics Market Size, Share, Trends and Forecast by Disease Stage, Test Type, End-User, and Region, 2025-2033

  • Report
  • 140 Pages
  • Global
From
Tuberculosis Diagnostics - Global Strategic Business Report - Product Image

Tuberculosis Diagnostics - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Tuberculosis Testing - Global Strategic Business Report - Product Image

Tuberculosis Testing - Global Strategic Business Report

  • Report
  • 423 Pages
  • Global
From

About the Tuberculosis Test Market

The Tuberculosis Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Tests are used to diagnose active tuberculosis, as well as to monitor the effectiveness of treatment. Tests can be divided into two categories: those that detect the presence of the bacteria, and those that detect the body's immune response to the bacteria. The most common tests are the tuberculin skin test, the interferon-gamma release assay, and the nucleic acid amplification test. The Tuberculosis Test market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.